Patents by Inventor Matthew Douglas Breyer

Matthew Douglas Breyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic uses for VEGFR1 antibodies
    Patent number: 9670284
    Abstract: The present invention relates to methods of using VEGFR1 antibodies for the treatment of chronic kidney disease.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: June 6, 2017
    Assignee: Eli Lilly and Company
    Inventors: Zhonghua Qi, Matthew Douglas Breyer, Ling Liu
  • THERAPEUTIC USES FOR VEGFR1 ANTIBODIES
    Publication number: 20140271675
    Abstract: The present invention relates to methods of using VEGFR1 antibodies for the treatment of chronic kidney disease.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: ELI LILLY AND COMPANY
    Inventors: ZHONGHUA QI, MATTHEW DOUGLAS BREYER, LING LIU
  • Therapeutic uses of soluble alpha-Klotho
    Patent number: 8778887
    Abstract: The present invention relates to therapeutic uses of soluble alpha-Klotho.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: July 15, 2014
    Assignee: Eli Lilly and Company
    Inventors: Matthew Douglas Breyer, Linda Maureen O'Bryan, Rosamund Carol Smith
  • THERAPEUTIC USES OF SOLUBLE ALPHA-KLOTHO
    Publication number: 20120232024
    Abstract: The present invention relates to therapeutic uses of soluble alpha-Klotho.
    Type: Application
    Filed: December 15, 2010
    Publication date: September 13, 2012
    Applicant: ELI LILLY AND COMPANY
    Inventors: Matthew Douglas Breyer, Linda Maureen O'Bryan, Rosamund Carol Smith